Some pretty concerning language now being used in the Annual report;
Future developments and resultsContinue the commercialisation strategy for the PeriCoach namely:
• Executing the commercialisation strategy for the PeriCoach is focussed on the following milestones:
• Building ‘best-in-class’ conservative treatment for pelvic floor conditions, with expansion from the current focus on urinary incontinence to include pelvic organ prolapse, a condition which affects up to 10% of all women at some stage of their lives.
• Validate and extend clinical credibility and effectiveness of PeriCoach
(sounds like big potential partners haven’t seen enough evidence or proof the device works)
• Confirming market acceptance while creating a positive sales environment
(is this an admission that there is a major [market] reluctance to inserting this device, regardless of the potential benefits?)
• Securing a competitive partnering agreement with a major multinational company with theresources to make the PeriCoach a global success.
(they have used ‘securing’ over ‘advancing negotiations’ for a partnering agreement - back to square one?)
Gotta say I’m more than a little worried guys.
GLTAH
